Varied synergistic activity of colistin and polymyxin B with meropenem, rifampicin and tigecycline: An in vitro study on carbapenem resistant Acinetobacter baumannii from India

Significant concordance between the CBM and TKA was observed. Our findings suggest that subinhibitory antimicrobial concentrations in combinations can improve therapeutic efficacy and minimize polymyxin side effects. Additionally, in vivo studies are warranted to optimize the combinational therapy.